On 30 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. repurchased 203,000 A shares on the Shanghai Stock Exchange at a repurchase price ranging from RMB 63.20 to RMB 63.28 per share. The total consideration amounted to RMB 12,835,167.

After the repurchase, the closing balance of issued shares (excluding treasury shares) stands at 6,362,732,164, while treasury shares total 16,270,110, leading to an overall issued share count of 6,379,002,274. The repurchased shares are held as treasury shares, in compliance with the relevant listing and regulatory requirements.